BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4172776)

  • 1. An association between cutaneous vasculitis and decreased blood-fibrinolytic activity.
    Cunliffe WJ
    Lancet; 1968 Jun; 1(7554):1226-8. PubMed ID: 4172776
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolytic therapy for vasculitis of atrophie blanche.
    Gilliam JN; Herndon JH; Prystowsky SD
    Arch Dermatol; 1974 May; 109(5):664-7. PubMed ID: 4828532
    [No Abstract]   [Full Text] [Related]  

  • 3. The association between cutaneous vasculitis and decreased blood fibrinolytic activity.
    Cunliffe WJ; Menon IS
    Br J Dermatol; 1971 Feb; 84(2):99-105. PubMed ID: 4396169
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and laboratory double-blind investigation on effect of fibrinolytic therapy in patients with cutaneous vasculitis.
    Dodman B; Cunliffe WJ; Roberts BE; Sibbald R
    Br Med J; 1973 Apr; 2(5858):82-4. PubMed ID: 4573315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fibrinolytic treatment in malignant atrophic papulosis.
    Delaney TJ; Black MM
    Br Med J; 1975 Aug; 3(5980):415. PubMed ID: 1156791
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
    Menon IS
    Acta Univ Carol Med Monogr; 1972; 52():19-23. PubMed ID: 4669824
    [No Abstract]   [Full Text] [Related]  

  • 7. Malignant atrophic papulosis of Degos. Report of a patient who failed to respond to fibrinolytic therapy.
    Howsden SM; Hodge SJ; Herndon JH; Freeman RG
    Arch Dermatol; 1976 Nov; 112(11):1582-8. PubMed ID: 791153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary report of beneficial effect of phenformin in combination with ethyloestrenol in treatment of cutaneous vasculitis and Behçet's syndrome.
    Menon IS; Cunliffe WJ; Dewar HA
    Postgrad Med J; 1969 May; 45():62-6. PubMed ID: 5364317
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant atrophic papulosis (Degos' disease).
    Black MM
    Int J Dermatol; 1976; 15(6):405-11. PubMed ID: 1279068
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinolysis in cutaneous vasculitis.
    Cunliffe WJ
    Proc R Soc Med; 1971 Sep; 64(9):928. PubMed ID: 5114293
    [No Abstract]   [Full Text] [Related]  

  • 11. Dowling oration 1975. Fibrinolysis and vasculitis.
    Cunliffe WJ
    Clin Exp Dermatol; 1976 Mar; 1(1):1-16. PubMed ID: 131664
    [No Abstract]   [Full Text] [Related]  

  • 12. Mode of action of phenformin plus ethyloestrenol on fibrinolysis.
    Fearnley GR; Chakrabarti R; Evans JF
    Lancet; 1971 Apr; 1(7702):723-5. PubMed ID: 4101428
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: Clinical and laboratory double-blind investigation on the effect of fibrinolytic therapy in patients with cutaneous vasculitis.
    Cunliffe WJ; Dodman B; Roberts BE
    Ann Rheum Dis; 1973 Nov; 32(6):591-2. PubMed ID: 4586510
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral fibrinolytic agents.
    Fearnley GR; Chakrabarti R
    Br Med J; 1968 Aug; 3(5616):498. PubMed ID: 5666808
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
    Fearnley GR; Chakrabarti R; Hocking ED
    Lancet; 1967 Nov; 2(7524):1008-11. PubMed ID: 4168522
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinolytic activity and coronary-artery disease.
    Naimi S; Proger S
    Lancet; 1968 Jun; 1(7554):1250-1. PubMed ID: 4172804
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenformin and ethyloestrenol in recurrent deep venous thrombosis (DVT).
    Hedner U; Nilsson IM; Isacson S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):372-80. PubMed ID: 63424
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenformin and stanozolol in blood fibrinolytic activity.
    Menon IS; Cunliffe WJ; Weightman D; Dewar HA
    Br Med J; 1970 Feb; 1(5693):428. PubMed ID: 4244848
    [No Abstract]   [Full Text] [Related]  

  • 19. Experiences in the use of fibrinolytic agents in Behcet's syndrome.
    Kirk J; Handley DA
    Australas J Dermatol; 1972 Apr; 13(1):5-10. PubMed ID: 5082495
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.
    Fearnley GR; Chakrabarti R
    Lancet; 1966 Oct; 2(7467):757-61. PubMed ID: 4162320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.